Asahi Kasei Therapeutics Corporation
16 clinical trials · Sponsor
◉ Watch Asahi Kasei Therapeutics Corporation
| Record | Firm | Date |
|---|---|---|
| Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes (NCT05227677) | Asahi Kasei Therapeutics Corporation | 2022-08-15 |
| First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) (NCT04483297) | Asahi Kasei Therapeutics Corporation | 2020-11-18 |
| Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis (NCT03471988) | Asahi Kasei Therapeutics Corporation | 2018-04-16 |
Track Asahi Kasei Therapeutics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.